This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92823273
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunu de 2019 scientific article published on 17 June 2019 наукова стаття, опублікована 17 червня 2019 wetenschappelijk artikel
p:P577
wds:Q92823273-98770B8A-5EA0-426D-B8E1-1D92A6496C4D
wdt:P577
2019-06-17T00:00:00Z
p:P2093
wds:Q92823273-0904A97D-362C-4681-AF95-FD7D63F00DE5
wdt:P2093
Sara Sabbagh
rdfs:label
Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
skos:prefLabel
Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
schema:name
Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
p:P50
wds:Q92823273-67805EB9-DA7D-43DD-A28E-579A74DD6557 wds:Q92823273-6BCFFFDE-6329-4BED-AC7E-2F95FCDC2E00 wds:Q92823273-8C7F5C7F-326E-4F63-9240-4E15A001C893 wds:Q92823273-DF7F614C-8260-4B98-9818-406E69492246
wdt:P50
wd:Q90281760 wd:Q30510395 wd:Q55437081 wd:Q37373352
p:P1476
wds:Q92823273-F55F021C-1809-4A76-A337-BAD452C9F577
wdt:P1476
Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
p:P31
wds:Q92823273-4E4E814B-27B2-4ADA-9618-CB1515EF0DAB
wdt:P31
wd:Q13442814
p:P921
wds:Q92823273-DE693880-5A0C-4D02-8314-DC92A88E17FC
wdt:P921
wd:Q1153419
p:P698
wds:Q92823273-84FA7494-0235-41CB-9A6D-E35A27C85536
wdtn:P698
n9:31208959
wdt:P698
31208959
p:P1433
wds:Q92823273-2C536814-E62F-4034-9CFA-7E0C28EF995A
wdt:P1433
wd:Q4767876
p:P356
wds:Q92823273-5D064C8F-AA96-4A2A-8859-8219EB35E9DA
wdtn:P356
n12:ANNRHEUMDIS-2019-215693
wdt:P356
10.1136/ANNRHEUMDIS-2019-215693